Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.

The epidemic of out-of-control generative artificial intelligence in litigation filings has metastasized to a False Claims Act (FCA) lawsuit against ...

CVS Health posted strong second-quarter results and raised its full-year guidance following strong performances in its Aetna and pharmacy segments, but its healthcare delivery segment remains under ...

Footage from a cellphone was initially thought to show a storm drain being used by a homeless person—highlighting concerns in the state about homelessness.

In June, Stanford Health Care announced a partnership with Kivo Health to deliver “virtual first,” “AI powered” pulmonary rehabilitation (PR) to their patients with COPD. Stanford Health Care closed ...

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

As policymakers in the U.S. and globally consider how to govern artificial intelligence technology, Berkeley researchers have ...